Form 4: ESTA Director Sells Shares Under 10b5-1 Plan

Juan Jose Chacon Quiros, a director at Establishment Labs Holdings Inc., sold 3,575 common shares for a weighted average price of $60.075 per share under a pre-arranged trading plan.

Summary

• Juan Jose Chacon Quiros, a Director of Establishment Labs Holdings Inc. (ESTA), reported a sale of common shares.
• The transaction involved the disposition of 3,575 common shares on March 25, 2026.
• The shares were sold at a weighted average price of $60.075 per share, with individual trades ranging from $60.00 to $60.32.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
• Following the transaction, Juan Jose Chacon Quiros directly holds 45,193 common shares.
• Additionally, 1,220,004 common shares are indirectly held by Sariel Group Ltd., where the Reporting Person is a shareholder with voting and dispositive power, though beneficial ownership is disclaimed except for pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale was conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not a reaction to recent material non-public information, thus mitigating any negative sentiment typically associated with insider sales.

Negatives

• A director's sale of shares, even under a pre-arranged plan, reduces their direct ownership stake in the company.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are common for various reasons including personal financial planning, diversification, or liquidity needs. Sales executed under a Rule 10b5-1 trading plan are pre-scheduled and do not necessarily reflect a change in the insider's view of the company's future prospects, as the plan is established when the insider is not in possession of material non-public information.

Corporate Governance

Related Party Transactions

• 1,220,004 common shares are indirectly held by Sariel Group Ltd., a entity in which the Reporting Person is a shareholder and holds voting and dispositive power. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in a director's direct stake, but the pre-planned nature under Rule 10b5-1 suggests no immediate negative implications for company outlook.

Key Dates

Recommendation

The transaction is a routine insider sale executed under a Rule 10b5-1 trading plan, which is typically established for personal financial management and diversification rather than as a signal about the company's future performance. The relatively small number of shares sold compared to the director's total holdings (direct and indirect) does not suggest a significant change in the investment thesis for Establishment Labs Holdings Inc. Therefore, a 'hold' recommendation is appropriate, as this event alone does not warrant a change in investment strategy.

Keywords

ESTA, Establishment Labs, Form 4, Insider Trading, 10b5-1 Plan, Director Sale, Share Transaction